🟢 Citius Pharmaceuticals is trading 5.9% up with no clear catalyst identified

Citius Pharmaceuticals is trading at $0.59, up 5.85%; no clear company-specific catalyst for the November 6 move was identified.

• Citius Oncology announced positive LYMPHIR quality-of-life results on November 4, but the report does not link them to the November 6 price change.
• Healthcare was down, opposite this stock’s move, and does not explain the gain. No volume or activity data was provided, limiting trading context.